All In MedTech

FDA Clearance Tracker · P900009-S044

Exogen Ultrasound Bone Healing System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 20, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 20, 2019

Approved

Time to decision

178 days

Received Jun 25, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P900009-S044
Device name
Exogen Ultrasound Bone Healing System
Applicant location
Durham, NC
Received
Jun 25, 2019
Decided
Dec 20, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P900009

Device type

Device class
Class II
Regulation
21 CFR 890.5870

Every decision under product code LOF

FDA's approval statement

As written in FDA's record.

Approval for modified indications for use to include adjunctive use in patients with internal or external fracture fixation hardware present, patients undergoing treatment for infection at the fracture site, and patients believed to have diminished bone quality.

Source documents

Other decisions for Bioventus, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.